Jing Liu

Title: Innovations of Jing Liu: Pioneering Bivalent Compounds for Disease Treatment

Introduction

Jing Liu is an accomplished inventor based in Oradell, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the development of bivalent compounds for therapeutic applications. With a total of 3 patents, Liu's work is paving the way for innovative treatments for various diseases.

Latest Patents

Liu's latest patents focus on Tropomyosin receptor kinase (TRK) degradation compounds and methods of use. These disclosures relate to bivalent compounds, which are bi-functional small molecule compounds. The compositions comprising these bivalent compounds are designed for the treatment of specific diseases in subjects in need. Additionally, the patents include methods for identifying such bivalent compounds, showcasing Liu's commitment to advancing medical science.

Career Highlights

Throughout his career, Jing Liu has worked with notable companies, including Cullgen (Shanghai), Inc. and Cullgen, Inc. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Liu has had the opportunity to work alongside talented individuals such as Liqun Chen and Xiaoran Han. These collaborations have further enriched his research and development efforts in the realm of biochemistry.

Conclusion

Jing Liu's innovative work in the development of bivalent compounds represents a significant advancement in the treatment of diseases. His contributions to the field are noteworthy and continue to inspire future research and innovation.